reference/2266830

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2266830

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article
endingPage	442
issn	0959-4973
issueIdentifier	6
pageRange	437-442
publicationName	Anti-Cancer Drugs
startingPage	437
bibliographicCitation	Fazeny-Dörner B, Veitl M, Wenzel C, Piribauer M, Rössler K, Dieckmann K, Ungersböck K, Marosi C. Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme. Anticancer Drugs. 2003 Jul;14(6):437–42. doi: 10.1097/00001813-200307000-00008. PMID: 12853885.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f3b43880c186ffa5a66260714dfd302 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3f3d817fa5de15ee7ca766c2cb51294 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40d2f54107a5462cc732931bfcdc1d1c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfa53c388f28e3865989b01e46ed52e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e64cc360ea85738ce6850fc7a379c9c8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6fc366774b42554f7fe75fe683ec18b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95bf0e2fe838ca8717973f318ce6362b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4c1129f21f97dbbe32d46da174296a3
date	200307
identifier	https://doi.org/10.1097/00001813-200307000-00008 https://pubmed.ncbi.nlm.nih.gov/12853885
isPartOf	https://portal.issn.org/resource/ISSN/0959-4973 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1267
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme
discusses	http://id.nlm.nih.gov/mesh/M0153576 http://id.nlm.nih.gov/mesh/M0005636 http://id.nlm.nih.gov/mesh/M0015421 http://id.nlm.nih.gov/mesh/M0014925
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D005909Q000188 http://id.nlm.nih.gov/mesh/D016879Q000379
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009943Q000008 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D003606Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009607Q000627 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005909Q000532 http://id.nlm.nih.gov/mesh/D005909Q000401 http://id.nlm.nih.gov/mesh/D009607Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918763 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104799 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2942 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398738 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6847 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105035 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7078

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789878 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856490 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127830723 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867724 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53786765

Total number of triples: 64.